Acute Leukemia

October 26, 2015

Cyclosporin A Reduces Anthracycline Resistance in Acute Myeloid Leukemia

Charles H. Weaver, MD
February 18, 2015

Intravenous Administration of Erwinaze® Approved by FDA

Charles H. Weaver, MD
December 8, 2014

Actinium Receives Orphan-drug Designation from FDA for Actimab-A

Charles H. Weaver, MD
January 18, 2013

CPX-351 Highly Active in Older Patients with AML

Charles H. Weaver, MD
August 17, 2012

Marqibo Approved for Treatment of Philadelphia-Negative ALL

Charles H. Weaver, MD
April 20, 2012

One Subset of Acute Lymphoblastic Leukemia is Best Treated with Chemotherapy

Charles H. Weaver, MD
January 1, 2012

Acute Myeloid Leukemia Screening/Prevention Overview

Charles H. Weaver, MD
June 14, 2011

Dacogen Effective for Treating Elderly Patients with Acute Myeloid Leukemia AML

Charles H. Weaver, MD
July 28, 2010

Newly Diagnosed Ph+ ALL Patients Benefit from Sprycel Chemotherapy Combination

Charles H. Weaver, MD
May 5, 2009

Compressed Dose-dense Induction with S-HAM Effective for AML Patients

Charles H. Weaver, MD
March 8, 2009

Prolonged Therapy for Poor-Prognosis Acute Myeloid Leukemia may Reduce Relapses

Charles H. Weaver, MD
March 8, 2009

Parental Use of Some Medications Associated with Incidence of Childhood ALL

Charles H. Weaver, MD